Chisari LM, Antonino G, Chisari G, Borzì AM, Chisari CG. Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report.
Ann Med Surg (Lond) 2020;
55:174-6. [PMID:
32489660 DOI:
10.1016/j.amsu.2020.04.020]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 03/14/2020] [Accepted: 04/01/2020] [Indexed: 11/22/2022] Open
Abstract
The phases of a cutaneous infection are initially the adhesion of the microorganism to the cells of the host, followed by the invasion of the tissues, than the elaboration of toxins and the escape from the defense systems of the host. The Human Amniotic Membrane (HAM) is extracted from the placenta of donors after caesarean section. The amnios is characterized by a monolayer of epithelial cells, a basement membrane and an avascular stroma of collagen. The HAM showed to promote chronic wound healing. We evaluated the “in vivo” and "in vitro" activity and efficacy of the HAM in subjects with chronic diabetic skin lesion. This clinical case showed that the HAM promote the wound healing of complex chronic skin lesion in a follow-up period of 6 months after the first graft.
We evaluated the Human Amniotic Membrane (HAM) activity and efficacy in the treatment of diabetic skin lesion.
The Human Amniotic Membrane showed to facilitating cell regeneration in skin lesions.
The Human Amniotic Membrane showed antimicrobial effects, favoring the restoration of skin surface defense systems.
The Human Amniotic Membrane has proved to be an excellent dermal substitute for the treatment of non-healing ulcers.
Collapse